Lakeridge Health Oshawa, formerly Oshawa General Hospital, is a hospital located in Oshawa, Ontario, Canada. It was founded in August 1910 in a two-story building, and major additions were made in the 1920s. "G" Wing opened in 1970 on the occasion of the hospital's 60th anniversary.

There are 363 beds in Lakeridge Health Oshawa.

During the past decade, Lakeridge Health Oshawa conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 23 clinical trials were completed, i.e. on average, 57.5% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 15 clinical trials were completed. i.e. 78.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lakeridge Health Oshawa" #1 sponsor was "NCIC Clinical Trials Group" with 17 trials, followed by "Canadian Cancer Trials Group" with 9 trials sponsored, "National Cancer Institute (NCI)" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lakeridge Health Oshawa" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "Eastern Cooperative Oncology Group" with 4 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 66 trials.

According to Clinical.Site data, the most researched conditions in "Lakeridge Health Oshawa" are "Breast Cancer" (8 trials), "Lung Cancer" (4 trials), "Cancer" (3 trials), "Colorectal Cancer" (3 trials) and "Prostatic Neoplasms" (3 trials). Many other conditions were trialed in "Lakeridge Health Oshawa" in a lesser frequency.

Most popular intervention types in "Lakeridge Health Oshawa" are "Drug" (58 trials), "Other" (17 trials), "Biological" (14 trials), "Radiation" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Carboplatin" (5 trials), "Pembrolizumab" (5 trials), "Paclitaxel" (4 trials) and "Quality-of-Life Assessment" (4 trials). Other intervention names were less common.

The vast majority of trials in "Lakeridge Health Oshawa" are 58 trials for "All" genders, 10 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Lakeridge Health Oshawa". undefined are not yet recruiting, 10 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 45 completed trials in Lakeridge Health Oshawa, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Lakeridge Health Oshawa, 1 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 45 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".